dne pharma

DNE Pharma is a specialized pharmaceutical company based in Oslo, Norway, primarily focused on the development and supply of treatments for addiction and opioid dependence. As a leading provider of opioid substitution therapy (OST) in the Nordic region, the company maintains a robust portfolio featuring methadone and buprenorphine products. DNE Pharma emphasizes high-quality manufacturing and reliable distribution to support public health initiatives and specialized clinics. Since its acquisition by AddLife AB in 2021, the company has operated as part of a larger European life science network, leveraging expanded resources to serve the Nordic and international markets.